A detailed history of Grey Street Capital, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Grey Street Capital, LLC holds 19,662 shares of GILD stock, worth $1.76 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares
19,662
Holding current value
$1.76 Million
% of portfolio
0.19%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Aug 09, 2024

BUY
$71.58 - $87.29 $1.41 Million - $1.72 Million
19,662 New
19,662 $1.44 Billion

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $112B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Grey Street Capital, LLC Portfolio

Follow Grey Street Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Grey Street Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Grey Street Capital, LLC with notifications on news.